Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now full pipeline small index

Sinusitis: full-pipeline trial registry

1 of 13 indexed Sinusitis trials are currently recruiting.

Corpus placement: #1,315 of 28,707 conditions by registered trial count.

13 US clinical trials · 1 currently recruiting · #1,315 of 28,707 conditions by registered trial count

Sinusitis: 13 US clinical trials tracked, 1 recruiting.

Sinusitis is the subject of 13 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Greg Davis, running 1 of these trials.

Enrollment posture brief

Registry condition sinusitis

OPEN 1 | RECR 8% | LATE 2 | EARLY 3 | RANK #1315 | SPON 1

Nearest open-share peer: Untreated Adult Acute Myeloid Leukemia (8% recruiting · 13 trials)

ACL Injury61.5%Acute Biphenotypic Leukemia46.2%Accidental Falls30.8%Actinic Keratoses23.1%Sinusitis (this)8%
Open-enrollment share among volume-matched conditions near Sinusitis

Sinusitis lists 1 open slots (8% of 13 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Sinusitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Sinusitis is recruiting below its size-band peers.

    1 of 13 indexed trials (7.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Sinusitis trials is spread across many organizations.

    Greg Davis accounts for 1 of 13 trials (7.7%). 13 distinct sponsors appear on at least one study for this condition label.

  3. Most Sinusitis trials plan to enrol fewer than 100 people.

    Median target enrolment is 68 among the 13 trials that report a genuine target (sentinel values excluded). 9 of those (69.2%) plan for fewer than 100 participants.

  4. Sinusitis splits between interventional and observational designs.

    7 interventional and 6 observational studies make up this index (53.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 22Phase 42

Open and recent trials

13 total, page 1 of 1

RECRUITING NA 68 participants

How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.

Geisinger Clinic

NCT06495021

ACTIVE NOT RECRUITING 420 participants

Reducing Antibiotic Use by Implementation of Stewardship in Primary and Urgent Care

Children's Hospital of Philadelphia

NCT07217002

ACTIVE NOT RECRUITING 60 participants

High Resolution Micro OCT Imaging

University of Alabama at Birmingham

NCT03256773

ACTIVE NOT RECRUITING Phase 4 30 participants

Dupixent Study for Alternate Administration

Madigan Army Medical Center

NCT06750471

COMPLETED Phase 4 315 participants

Clinical Trial of the Treatment of Acute Sinusitis With Standard-dose Versus High-dose Amoxicillin/Clavulanate

Albany Medical College

NCT02340000

COMPLETED NA 260 participants

The Polymerase Chain Reaction (PCR) Analysis of Nasal Polyps for Fungal DNA

University of California, San Francisco

NCT00739921

COMPLETED 198 participants

Medical Therapy Versus Balloon Sinus Dilation for Patients With Chronic Rhinosinusitis

Integra LifeSciences Corporation

NCT01685229

COMPLETED Phase 2 72 participants

A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To

Pfizer

NCT00232154

COMPLETED 68 participants

Validation of the Facial and Cephalic Pain Inventory

Greg Davis

NCT01001039

COMPLETED 33 participants

Near Infrared Transillumination of the Paranasal Sinuses

University of California, Irvine

NCT00543998

COMPLETED 20 participants

Non-Rhinologic Etiologies of Headaches and Facial Pain in Tertiary Care Setting

Penn State University

NCT00355160

COMPLETED Phase 2 16 participants

Nasally Delivered Pulmozyme for Sinusitis in Cystic Fibrosis

University of Vermont

NCT00416182

COMPLETED Phase 1 6 participants

Concentration of Itraconazole Solution in Nasal Secretions

Mayo Clinic

NCT00588016

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 2
Phase 4 2

Named interventions

Most-linked intervention names on Sinusitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Pulmozyme (dornase alfa) Drug
1 trials
Nasal swab under endoscopic guidance Procedure
1 trials
Medical Management Drug
1 trials
Balloon sinus dilation Device
1 trials
Optical Measurement transillumination Device
1 trials
high dose amoxicillin/clavulanate Drug
1 trials
standard dose amoxicillin/clavulanate Drug
1 trials
Serum pregnancy test (for women of child-bearing potential) Procedure
1 trials

US sites by state

Facility locations filed on Sinusitis trials. A trial with sites in several states counts in each.

Pennsylvania 4 trials
California 3 trials
Washington 2 trials
Kentucky 2 trials
Illinois 2 trials
Georgia 2 trials
Florida 2 trials
Alabama 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Sinusitis page

13 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Sinusitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Greg Davis sponsors the most Sinusitis trials on record, review their full trial history before evaluating a specific study. See Greg Davis's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Sinusitis condition card totals 13 registered trials; most-linked intervention Pulmozyme (dornase alfa); top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.